Cognitive Health

Sixty per cent of the human brain consists of fat, polyunsaturated fatty acids such as DHA in particular. DHA is essential to brain functions, but it is also essential for the prevention of brain cell damage. Poor memory, and particularly dementia such as Alzheimer’s disease, is associated with low concentrations of brain DHA. People with a regular intake of seafood have a lower risk of developing dementia.

In a clinical study of Alzheimer patients, it was shown that EPAX 1050 TG reduced memory decline in patients with an early stage of the disease. EPAX 1050 TG, which has a high concentration of DHA, provides nutritional support against age-related memory decline.

Click here to see articles about Omega-3 and Cognitive Health
 
 

EPAX 1050 TG

60 mg/g EPA
430 mg/g DHA

EPAX 1050 TG Specification
 EPAX 1050 TG Nutritional values

 

 
 
EPAX News & Events

Trygg Pharma AS has acquired 100 percent of the shares in EPAX AS

AALESUND, Norway (Sept. 03, 2010) — Trygg Pharma AS, a company jointly owned by Aker BioMarine ASA, a Norwegian biotechnology company, and Lindsay Goldberg, a New York-based investment fund, has acquired 100 percent of the shares in EPAX AS from Austevoll Seafood ASA. EPAX AS is a world-leading supplier of concentrated, marine-derived omega-3 formulas that target specific health conditions.

Read press release



 
 

Epax Unveils Latest Study At Issfal 2010

Leading Omega-3 supplier, EPAX AS, will present results from studies related to the treatment and prevention of metabolic syndrome and Type 2 Diabetes at the ISSFAL1 conference which runs from 29th May – 2nd June in Maastricht, Netherlands.

Read press release

 
 

EPAX invites you to explore our enviromental stewardship policy


www.epax.com/ecovision

 
 
EPAX AS
PO Box 2047
NO-6028 Aalesund, Norway

Site Map    •    Disclaimer

© Copyright 2008  EPAX AS

Tlf: +47 70 13 59 60
Fax: +47 70 13 59 61
E-mail: epax@epax.com
sales@epax.com